We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GENRUI BIOTECH INC.

Eurofins Technologies

  Gold Eurofins Technologies, part of the Eurofins Scientific group, is a fast-growing, global provider of diagnostic test k... read more Featured Products: More products

Download Mobile App





Eurofins Launches Upgraded RT-PCR Kit for Identification of Mutations Associated with SARS-CoV-2 Variants of Concern

By LabMedica International staff writers
Posted on 23 Mar 2021
Print article
Illustration
Illustration
Eurofins Technologies (Budapest, Hungary) has launched GSD NovaType II, its upgraded RT-PCR kit for the identification of mutations associated with SARS-CoV-2 variants of concern.

The first GSD NovaType RT-PCR kit was launched in February 2021 and quickly supported health authorities in the detection of variants in more than 100,000 COVID-19 positive patients across Europe. The new GSD NovaType II kit can now detect the N501Y and E484K mutations common to most VOC (Variants of Concern) and the K417N mutation (specific to B.1.351 first identified in South Africa), with a high sensitivity.

The GSD NovaType II kit delivers results under two hours. It is therefore well suited to timely screening and relieving sequencing capacities for use in epidemiological studies. Fast-paced screening for these emerging variants that may spread more easily, cause more severe disease, or may escape the body’s immune response even post vaccination, is a critical element to containing the pandemic. Laboratories can use the GSD NovaType II SARS-CoV-2 kit to identify genomic mutations in extracted samples that have already been tested positive for the presence of SARS-CoV-2 RNA.

The GSD NovaType II SARS-CoV-2 kit contains specific primers and probes for amplification and simultaneous detection of specific RNA sequences which represent specific SARS-CoV-2 S gene variants. It is delivered in a ready-to-use format with optional interpretation software. The assay has been validated on the AriaMxTM and AriaDxTM qPCR platforms from Agilent Technologies and will soon be validated on additional thermocyclers. The assay is currently for Research Use Only, but the CE-IVD mark is expected shortly.

Gold Supplier
SARS-CoV-2 Antibody Test
Epithod SARS-CoV-2 qAb
Hematology Analyzer
DxH 560 AL
New
SARS-CoV-2 PCR Assay
AppliedBiosystems TaqCheck SARS-CoV-2 Fast PCR Assay Kit
New
SARS-CoV-2 Recombinant Antigens
SARS-CoV-2 Recombinant Antigens

Print article
BIOHIT  Healthcare OY

Channels

Molecular Diagnostics

view channel
Image: Randox Discovery Diagnostic Analyzer Wins 2021 Red Dot Award for High Design Quality (Photo courtesy of Randox Laboratories)

Randox Discovery Diagnostic Analyzer Wins 2021 Red Dot Award for High Design Quality

Randox Laboratories’ (Crumlin, UK) Discovery, a diagnostic analyzer which can consolidate molecular and immunoassay testing on one compact benchtop platform, has received the 2021 Red Dot Award for High... Read more

Industry

view channel
Image: Eppendorf Centrifuge 5910 Ri (Photo courtesy of Eppendorf AG)

Eppendorf Introduces Multipurpose Centrifuge 5910 Ri to Accelerate Results

Eppendorf AG (Hamburg, Germany) has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri, a successor to the company’s popular Centrifuge 5910 R.... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.